Please enable JavaScript to continue using this application.

Compare $BCAX vs $TRAX | Chartloom

Compare

$BCAX vs $TRAX

Bicara Therapeutics Inc · First Tracks Biotherapeutics Inc

BCAX

Bicara Therapeutics Inc

TRAX

First Tracks Biotherapeutics Inc

Compare $BCAX vs $TRAX

Comparing Bicara Therapeutics Inc and First Tracks Biotherapeutics Inc

BCAXBicara Therapeutics Inc

TRAXFirst Tracks Biotherapeutics Inc

BCAXBicara Therapeutics Inc

Market cap

$1.15B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

6.8%

52W performance

-2.8%

FCF yield

-11.8%

TRAXFirst Tracks Biotherapeutics Inc

Market cap

$1.11B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

67.6%

52W performance

67.6%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BCAX

TRAX

Detailed metrics comparison

BCAX

Bicara Therapeutics Inc

TRAX

First Tracks Biotherapeutics Inc

Market Cap

BCAX$1.15B

TRAX$1.11B

Enterprise Value

BCAX$1.05B

TRAX$943M

Price

BCAX$17.50

TRAX$31.85

P/E Ratio

BCAXN/A

TRAXN/A

P/S Ratio

BCAX0.00x

TRAX0.00x

EV/Sales

BCAX0.00x

TRAX0.00x

EV/EBITDA

BCAX0.00x

TRAX0.00x

P/B Ratio

BCAX2.49x

TRAX7.04x

P/FCF Ratio

BCAXN/A

TRAXN/A

EV/FCF

BCAX-7.79x

TRAX0.00x

PEG Ratio

BCAXN/A

TRAXN/A

Forward P/E (NTM)

BCAXN/A

TRAXN/A

Forward P/S (NTM)

BCAXN/A

TRAXN/A

Revenue (TTM)

BCAX$0

TRAX$0

Revenue Growth (YoY)

BCAXN/A

TRAXN/A

Forward Rev Growth

BCAX1358.6%

TRAX0.0%

Gross Margin (TTM)

BCAX0.0%

TRAX0.0%

Operating Margin (TTM)

BCAX0.0%

TRAX0.0%

EBITDA Margin (TTM)

BCAX0.0%

TRAX0.0%

Net Margin (TTM)

BCAX0.0%

TRAX0.0%

FCF Margin (TTM)

BCAXN/A

TRAXN/A

Net Income (TTM)

BCAX$-185M

TRAX$-84M

FCF (TTM)

BCAX$-135M

TRAX$0

EPS (TTM)

BCAX-$2.73

TRAX-$2.40

ROE (TTM)

BCAX-4149.0%

TRAX0.0%

ROA (TTM)

BCAX-3859.0%

TRAX0.0%

ROIC (TTM)

BCAX-4149.0%

TRAX0.0%

Cash

BCAX$97M

TRAX$168M

Debt

BCAX$0

TRAX$0

Net Cash/Debt

BCAX$97M

TRAX$168M

Current Ratio (TTM)

BCAX11.59x

TRAX14.28x

Quick Ratio (TTM)

BCAX11.44x

TRAX14.08x

Debt/Equity (TTM)

BCAX0.00x

TRAX0.00x

Debt/Assets (TTM)

BCAX0.0%

TRAX0.0%

Interest Coverage (TTM)

BCAXN/A

TRAXN/A

Net Debt/EBITDA (TTM)

BCAX0.00x

TRAX0.00x

Beta

BCAX0.94

TRAX1.60

52W Performance

BCAX-2.8%

TRAX67.6%

YTD Performance

BCAX6.8%

TRAX67.6%

% from 52W High

BCAX-43.5%

TRAX-36.2%

% from 52W Low

BCAX27.7%

TRAX116.4%

Asset Turnover (TTM)

BCAX0.00x

TRAX0.00x

FCF Yield (TTM)

BCAX-11.8%

TRAX0.0%

Earnings Yield (TTM)

BCAX-16.1%

TRAX-7.5%

Dividend Yield (TTM)

BCAXN/A

TRAXN/A

Rule of 40

BCAX0.0

TRAX0.0

EV/GP/RG

BCAXN/A

TRAXN/A

Ticker research

View BCAX research View TRAX research

Metric	BCAX Bicara Therapeutics Inc	TRAX First Tracks Biotherapeutics Inc
Market & Valuation
Market Cap	$1.15B	$1.11B
Enterprise Value	$1.05B	$943M
Price	$17.50	$31.85
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.49x	7.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.79x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1358.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-185M	$-84M
FCF (TTM)	$-135M	$0
EPS (TTM)	-$2.73	-$2.40
ROE (TTM)	-4149.0%	0.0%
ROA (TTM)	-3859.0%	0.0%
ROIC (TTM)	-4149.0%	0.0%
Financial Health
Cash	$97M	$168M
Debt	$0	$0
Net Cash/Debt	$97M	$168M
Current Ratio (TTM)	11.59x	14.28x
Quick Ratio (TTM)	11.44x	14.08x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	1.60
52W Performance	-2.8%	67.6%
YTD Performance	6.8%	67.6%
% from 52W High	-43.5%	-36.2%
% from 52W Low	27.7%	116.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-11.8%	0.0%
Earnings Yield (TTM)	-16.1%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAX research	View TRAX research

Valuation

P/S Ratio

BCAX

0.00x

TRAX

0.00x

EV/FCF

BCAX

-7.79x

TRAX

0.00x

Growth & revenue

Forward Revenue Growth

BCAX

1358.6%

TRAX

0.0%

Profitability & performance

Gross Margin

BCAX

0.0%

TRAX

0.0%

ROE

TRAX

0.0%

BCAX

-4149.0%

FCF Yield %

TRAX

0.0%

BCAX

-11.8%

52-Week Performance

TRAX

67.6%

BCAX

-2.8%

Detailed metrics comparison

BCAX

Bicara Therapeutics Inc

TRAX

First Tracks Biotherapeutics Inc

Market Cap

BCAX$1.15B

TRAX$1.11B

Enterprise Value

BCAX$1.05B

TRAX$943M

Price

BCAX$17.50

TRAX$31.85

P/E Ratio

BCAXN/A

TRAXN/A

P/S Ratio

BCAX0.00x

TRAX0.00x

EV/Sales

BCAX0.00x

TRAX0.00x

EV/EBITDA

BCAX0.00x

TRAX0.00x

P/B Ratio

BCAX2.49x

TRAX7.04x

P/FCF Ratio

BCAXN/A

TRAXN/A

EV/FCF

BCAX-7.79x

TRAX0.00x

PEG Ratio

BCAXN/A

TRAXN/A

Forward P/E (NTM)

BCAXN/A

TRAXN/A

Forward P/S (NTM)

BCAXN/A

TRAXN/A

Revenue (TTM)

BCAX$0

TRAX$0

Revenue Growth (YoY)

BCAXN/A

TRAXN/A

Forward Rev Growth

BCAX1358.6%

TRAX0.0%

Gross Margin (TTM)

BCAX0.0%

TRAX0.0%

Operating Margin (TTM)

BCAX0.0%

TRAX0.0%

EBITDA Margin (TTM)

BCAX0.0%

TRAX0.0%

Net Margin (TTM)

BCAX0.0%

TRAX0.0%

FCF Margin (TTM)

BCAXN/A

TRAXN/A

Net Income (TTM)

BCAX$-185M

TRAX$-84M

FCF (TTM)

BCAX$-135M

TRAX$0

EPS (TTM)

BCAX-$2.73

TRAX-$2.40

ROE (TTM)

BCAX-4149.0%

TRAX0.0%

ROA (TTM)

BCAX-3859.0%

TRAX0.0%

ROIC (TTM)

BCAX-4149.0%

TRAX0.0%

Cash

BCAX$97M

TRAX$168M

Debt

BCAX$0

TRAX$0

Net Cash/Debt

BCAX$97M

TRAX$168M

Current Ratio (TTM)

BCAX11.59x

TRAX14.28x

Quick Ratio (TTM)

BCAX11.44x

TRAX14.08x

Debt/Equity (TTM)

BCAX0.00x

TRAX0.00x

Debt/Assets (TTM)

BCAX0.0%

TRAX0.0%

Interest Coverage (TTM)

BCAXN/A

TRAXN/A

Net Debt/EBITDA (TTM)

BCAX0.00x

TRAX0.00x

Beta

BCAX0.94

TRAX1.60

52W Performance

BCAX-2.8%

TRAX67.6%

YTD Performance

BCAX6.8%

TRAX67.6%

% from 52W High

BCAX-43.5%

TRAX-36.2%

% from 52W Low

BCAX27.7%

TRAX116.4%

Asset Turnover (TTM)

BCAX0.00x

TRAX0.00x

FCF Yield (TTM)

BCAX-11.8%

TRAX0.0%

Earnings Yield (TTM)

BCAX-16.1%

TRAX-7.5%

Dividend Yield (TTM)

BCAXN/A

TRAXN/A

Rule of 40

BCAX0.0

TRAX0.0

EV/GP/RG

BCAXN/A

TRAXN/A

Ticker research

View BCAX research View TRAX research

Metric	BCAX Bicara Therapeutics Inc	TRAX First Tracks Biotherapeutics Inc
Market & Valuation
Market Cap	$1.15B	$1.11B
Enterprise Value	$1.05B	$943M
Price	$17.50	$31.85
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.49x	7.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.79x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1358.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-185M	$-84M
FCF (TTM)	$-135M	$0
EPS (TTM)	-$2.73	-$2.40
ROE (TTM)	-4149.0%	0.0%
ROA (TTM)	-3859.0%	0.0%
ROIC (TTM)	-4149.0%	0.0%
Financial Health
Cash	$97M	$168M
Debt	$0	$0
Net Cash/Debt	$97M	$168M
Current Ratio (TTM)	11.59x	14.28x
Quick Ratio (TTM)	11.44x	14.08x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	1.60
52W Performance	-2.8%	67.6%
YTD Performance	6.8%	67.6%
% from 52W High	-43.5%	-36.2%
% from 52W Low	27.7%	116.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-11.8%	0.0%
Earnings Yield (TTM)	-16.1%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BCAX research	View TRAX research